Envestnet Asset Management’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.71M Buy
56,825
+1,635
+3% +$52.9K ﹤0.01% 3116
2025
Q4
$1.92M Sell
55,190
-5,245
-9% -$185K ﹤0.01% 2860
2025
Q3
$2.2M Sell
60,435
-2,852
-5% -$96.9K ﹤0.01% 2818
2025
Q2
$1.99M Sell
63,287
-3,972
-6% -$123K ﹤0.01% 2828
2025
Q1
$2M Buy
67,259
+735
+1% +$22K ﹤0.01% 2729
2024
Q4
$1.96M Sell
66,524
-6,456
-9% -$204K ﹤0.01% 2692
2024
Q3
$2.27M Buy
72,980
+2,409
+3% +$87.6K ﹤0.01% 2566
2024
Q2
$2.39M Buy
70,571
+606
+0.9% +$30.9K ﹤0.01% 2482
2024
Q1
$4.55M Buy
69,965
+1,391
+2% +$95.5K ﹤0.01% 2046
2023
Q4
$4.68M Buy
68,574
+14,305
+26% +$744K ﹤0.01% 1942
2023
Q3
$2.82M Buy
54,269
+35,876
+195% +$2.12M ﹤0.01% 2169
2023
Q2
$1.1M Buy
18,393
+13,371
+266% +$763K ﹤0.01% 2683
2023
Q1
$248K Sell
5,022
-103
-2% -$5.79K ﹤0.01% 3543
2022
Q4
$292K Buy
+5,125
New +$288K ﹤0.01% 3439

Other funds holding IMCR